Careers. Search jobs and apply. What we do Areas of opportunity. Why GSK? Working at GSK. Our locations. Physicians.
|
|
- Clare Chase
- 5 years ago
- Views:
Transcription
1 PRIMARY NAVIGATION Homepage About us Products Cers Our stories Research do Our prescripti medicines and vaccines Search jobs and apply Pharmaceuticals Vaccines Our csumer healthc do Areas of opportunity do R&D Csumer Healthc Our missi and strategy ViiV Healthc Why GSK? Working at GSK Business strategy Key achievements Stiefel dermatology Our locatis Our communities Corporate Experienced do Experienced Everyday health reports and presentatis Policies, codes and Policies, standards codes and standards Physicians Antibiotics Our history Undergraduates Fighting disease in the developing world Compulsory Optial Apprenticeships Students and apprenticeships R&D locatis Level Trials 2 in page (with people pages) sub- Our Level pages) use 2 page of animals (with sub- Meet our people
2 SECONDARY (AUDIENCE) NAVIGATION Csumers Healthc Investors Media Partnerships Business to business Ctact us Interactis with Interactis prescribers with prescribers Annual reports Press releases Our approach to partnering Ctract manufacturing Product Collaborating portfolio clinical trials and Social media Our as of interest Procurement terms Product pipeline Image and video library our partners say Compulsory Optial Business development Submit your ideas Corporate Level Trials 2 in page (with people subpages) Our Level use 2 page of animals (with subpages) Academic collaboratis HEADER Bioelectrics R&D Country selector Search Neglected tropical diseases FOOTER Sitemap Terms of use Accessibility Cookie policy Privacy Procurement GSK employees
3 Homepage The Homepage Products Products To serve up ctent (text, image, video, etc.) that delivers our core messages and supports our business strategy in clear and impactful ways. Our prescripti medicines and vaccines To describe the three core business as in which operate and provide individual links to each for specific product informati. Optially: to provide high level descriptis for ViiV and Stiefel, and provide links to each. Our csumer healthc About us About us To inform audiences who, what do, how operate and how governed. ViiV Healthc do Optially: to highlight key achievements, global and local and our history. Stiefel dermatology Our missi and strategy Key achievements Partnerships Corporate E.g. Corporate. Ctains the following subsectis: Global Local Policies, codes and Policies, standards codes and standards E.g. Policies, codes and standards: GSK Code of cduct Anti-Bribery and corrupti (ABAC) programme Our history
4 Cers Search jobs and apply Cers To explain and evidence our values and culture to potential employees. To explain the roles available in different parts of the business, direct users to current opportunities and provide them with the ability to apply. Our stories Our stories To surface global and/or local stories that support our business strategy and deliver our core messages in a compelling way and in a single destinati. Areas do of opportunity Optially: to present relevant locati-based informati and apprenticeship, undergraduate, graduate and postgraduate program informati. do R&D Why GSK? Working at GSK Business strategy Our locatis Our communities Experienced Experienced Everyday health Physicians Undergraduates Apprenticeships Students and apprenticeships Meet our people
5 Research Research To highlight the main as of science that focus, how cduct our, how work with doctors, what drives our R&D operatis, and our product pipeline. To surface our respsible business performance and future commitments across four as:, Our behavior, and. reports and presentatis Antibiotics Fighting disease in the developing world R&D locatis
6 Csumers Csumers To provide a space where csumers can identify themselves as an audience group and search for specific csumer or patient-related informati. Media Media To provide an a dedicated to latest s, resources and ctact informati, specifically targeted at the journalist and commentator audience groups. Press releases Healthc Interactis with Interactis prescribers with prescribers Healthc To provide a space for HCPs to find informati, clinical trials or anything else related to this audience group. Social media Image and video library Product Collaborating portfolio clinical trials and Investors Investors To surface key financials such as sh price, quarterly results, merger & acquisiti deals, disposals, etc. Business to business Ctract manufacturing Annual reports Procurement terms Product pipeline
7 Partnerships HEADER Country selector Our approach to partnering Search Our as of interest our partners say FOOTER Business development Sitemap Submit your ideas Terms of use Corporate Accessibility Academic collaboratis Cookie policy Bioelectrics R&D Neglected tropical diseases Privacy Ctact us Ctact Us To easily and quickly surface the correct ctact informati, according to regi and business a. Procurement GSK employees
Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes
Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes Scientific innovation is at the heart of everything we do. Scientific innovation is at the heart of our business and
More informationInnovation and the Changing Practice of Medicine
Innovation and the Changing Practice of Medicine Japan Medical Innovation Symposium David Epstein, Division Head Novartis Pharmaceuticals Tokyo, August 18, 2015 Agenda The Case for Innovation How Novartis
More informationMake an Executive Decision to Fight Cancer.
Make an Executive Decision to Fight Cancer. A Message from President and CEO, Edward J. Benz, Jr., MD President s circle Corporate Leaders Few institutions can match the strength and leadership that Dana-Farber
More informationBayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division
Bayer Inc. Science for a Better Life Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division Please review your career path to date, leading to your
More informationHigher Education Contribution to Health Science Innovation
Scottish University of the Year 2017 Higher Education Contribution to Health Science Innovation Professor Sir Pete Downes Principal, University of Dundee Lead Member for Health, Universities Scotland 28
More informationVanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sector Publishing Intelligence Limited
More informationThe Role of Patients in Transitions of Care
Play an Active Role It is crucial that you play an active role in your own healthcare. During treatment, you may see more than one provider. You also may visit more than one care setting. In each case,
More informationNature Research portfolio of journals and services. Joffrey Planchard
Nature Research portfolio of journals and services Joffrey Planchard 1 Springer Nature 1.0 Three main structural branches 2 Uniting some of the best brands in our field 3 4 Three main academic publishing
More informationSecurity and Risk Assessment in GDPR: from policy to implementation
Global Data Privacy Security and Risk Assessment in GDPR: from policy to implementation Enisa Workshop Roma - February 8, 2018 Nicola Orlandi Head of Data Privacy Pharma Nicola Orlandi Nicola Orlandi is
More informationFinding, Selecting & Working with a Behavioral Health Provider: How do you choose the right provider
Finding, Selecting & Working with a Behavioral Health Provider: How do you choose the right provider Congratulations. You are taking a positive step by deciding to seek help for yourself or someone else.
More informationDaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sector
More informationDraft Plan of Action Chair's Text Status 3 May 2008
Draft Plan of Action Chair's Text Status 3 May 2008 Explanation by the Chair of the Drafting Group on the Plan of Action of the 'Stakeholder' Column in the attached table Discussed Text - White background
More informationComprehensive Research Services
Comprehensive Research Services Scripps Health: At the Forefront of Clinical Research Scripps Health is a recognized leader in clinical research and has long been at the forefront of numerous medical breakthroughs.
More informationCollegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile The Business
More informationPlease also note that this is an annual survey, so many of these questions will be familiar to you if you completed a survey last year.
Welcome to the 2016 National MLP Survey Thank you for agreeing to participate in this survey. You are receiving this survey because you have indicated to the National Center for Medical-Legal Partnership
More informationSupporting Innovation through Regulation and Science
Supporting Innovation through Regulation and Science Larry O Dwyer, Scientific Affairs Manager PEARRL Regulatory Science Symposium 21 st June 2017, School of Pharmacy, UCC Overview of Presentation Drivers
More informationHealth & Social Care Industrial Innovation
Health & Social Care Industrial Innovation Mr Andrew Fowlie Scottish Government Health Innovations Team SHINE North Sea Region Program 2014 2020 Scotland s Medical Technologies Landscape Imaging Non Imaging
More informationPRECISE MEDICAL Self-revealing case Handout #1
OBEA Conference May 23-24, 2015 Entrepreneurship as it Relates to Financial Literacy Grant Russell, Associate Director of Undergraduate Programs School of Accounting and Finance, University of Waterloo
More informationWHO workshop on IP and Vaccines. Geneva 19 th -20 th April Introduction to the IP issues Christopher Garrison Consultant to WHO
WHO workshop on IP and Vaccines Geneva 19 th -20 th April 2004 Introduction to the IP issues Christopher Garrison Consultant to WHO Vaccine access, R&D and technology transfer issues are intimately linked
More informationData-Driven Evaluation: The Key to Developing Successful Pharma Partnerships
R&D Solutions for PHARMA & LIFE SCIENCES DRUG DISCOVERY & DEVELOPMENT Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships Summary For pharmaceutical companies to succeed, it is
More informationDefence and security engineering
Defence and security engineering 2018-2019 Symposia Symposia at Shrivenham provides a forum to Government agencies, military and civilian, industry and research establishments for the exploration and exchange
More informationScripps Florida. Accelerating Discoveries, Saving Lives. Presentation to the Urban Land Institute November 4, 2011
Scripps Florida Accelerating Discoveries, Saving Lives Presentation to the Urban Land Institute November 4, 2011 Alex Bruner Associate Vice President, Philanthropy 1921- Founding of the Scripps Metabolic
More informationSTRATEGIC FRAMEWORK Updated August 2017
STRATEGIC FRAMEWORK Updated August 2017 STRATEGIC FRAMEWORK The UC Davis Library is the academic hub of the University of California, Davis, and is ranked among the top academic research libraries in North
More informationSpeaking with One Voice Unifying Scripps Under a Master Brand Strategy
Forum for Healthcare Strategists Healthcare Marketing Summit April 30, 2014 Speaking with One Voice Unifying Scripps Under a Master Brand Strategy Lynne Field, Strategy Director, Monigle Associates, Inc.
More informationPharmaceutical Promotion in Medical (and Pharmacist) Training in the Netherlands: Readiness for Curriculum Change
Pharmaceutical Promotion in Medical (and Pharmacist) Training in the Netherlands: Readiness for Curriculum Change Brian Tielrooij September 7th, 2017 Introduction Indispensable role of medicines in society
More informationImminent Transformations in Health
Imminent Transformations in Health Written By: Dr. Hugh Rashid, Co-Chair Technology & Innovation Committee American Chamber of Commerce, Shanghai AmCham Shanghai s Technology and Innovation Committee and
More informationThe Value of Membership.
The Value of Membership. Driving the global transformation to a smarter, more sustainable world with digital solutions at its core. 2018 gesi.org Information and Communications Technology (ICT) innovators
More informationA Brief Introduction to the Regulatory Environment of Medical Device Supervision. CFDA Department of Legal Affairs Liu Pei
A Brief Introduction to the Regulatory Environment of Medical Device Supervision CFDA Department of Legal Affairs Liu Pei Development Trend of Medical Device Industry Development Opportunities of Medical
More informationElements of a global strategy and plan of action
INTERGOVERNMENTAL WORKING GROUP A/PHI/IGWG/1/5 ON PUBLIC HEALTH, INNOVATION AND 8 December 2006 INTELLECTUAL PROPERTY Agenda item 2.3 Elements of a global strategy and plan of action Progress to date in
More informationMalaria Vaccine Initiative
Malaria Vaccine Initiative Intellectual Property Rights and Vaccines in Developing Countries WHO Meeting April 19-20, 2004 Patricia Atkinson Roberts Sr. Officer, Commercialization & Corporate Partnerships
More informationJOHN JACK R. TUPMAN, JR CURRICULUM VITAE
JOHN JACK R. TUPMAN, JR CURRICULUM VITAE September 2018 John R. Tupman, Jr. is a consultant focused on business development and licensing in the life sciences industry. He is currently working as a consultant
More informationManagement to Host Conference Call at 8:30 a.m. ET today
Aclaris Therapeutics Reports Second Quarter 2016 Financial Results August 11, 2016 7:01 AM ET Management to Host Conference Call at 8:30 a.m. ET today MALVERN, Pa., Aug. 11, 2016 (GLOBE NEWSWIRE) -- (NASDAQ:ACRS),
More informationSTATEMENT of PRINCIPLES and RECOMMENDED CORPOR ATE PR ACTICES to PROMOTE GLOBAL HEALTH
STATEMENT of PRINCIPLES and RECOMMENDED CORPOR ATE PR ACTICES to PROMOTE GLOBAL HEALTH About these Principles These Principles are an articulation of our positions on corporate responsibility regarding
More informationRegulatory Science and Innovation: FDA s Role in Transformation of the MCM Enterprise
Regulatory Science and Innovation: FDA s Role in Transformation of the MCM Enterprise Jesse L. Goodman, MD, MPH Chief Scientist and Deputy Commissioner for Science and Public Health (Acting), presentation
More information70 th World Health Assembly May 2017 MSF Briefing on Medical Research and Development
70 th World Health Assembly May 2017 MSF Briefing on Medical Research and Development Overview Médecins Sans Frontières (MSF) welcomes the increased attention by WHO and Member States to find ways to ensure
More informationPerspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond
Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond ACI Forum on Structuring, Negotiating and Managing Life Sciences Collaborations and Acquisitions February 28,
More informationIntroduction to Science WoRx CSG 2012 National Leadership Conference. Adam Miller Director, State Health Policy State Policy and Government Affairs
Introduction to Science WoRx CSG 2012 National Leadership Conference Adam Miller Director, State Health Policy State Policy and Government Affairs Today s Discussion Who is Astellas? Why is Astellas so
More informationMedian Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing
More informationSPEAKER BIOGRAPHIES. Sarah Abbas
SPEAKER BIOGRAPHIES Sarah Abbas Sarah Abbas currently supports global medical education through collaboration with Pfizer Country Offices. She developed and managed the WW Investigator Initiated Research
More informationJURY BOARD BUSINESS/INVESTMENT. Pascal BECACHE Founding President, PBS, Healthcare Industry STRATEGY/BUSINESS
Hosted by : Pascal BECACHE Founding President, PBS, Healthcare Industry INNOLABS IDEAS CONTEST 21 st -22 nd June, Paris JURY BOARD BUSINESS/INVESTMENT Pascal is a seasoned executive with GM and Sales VP
More informationStanding Committee on the Law of Patents
E SCP/24/4 ORIGINAL: ENGLISH DATE: JUNE 29, 2016 Standing Committee on the Law of Patents Twenty-Fourth Session Geneva, June 27 to 30, 2016 PROPOSAL BY THE AFRICAN GROUP FOR A WIPO WORK PROGRAM ON PATENTS
More informationMedical Education Activities
Medical Education Activities Author: Marie-Claire PICKAERT EFPIA Deputy Director General BioMed Alliance Brussels, 9 November 2016 MCP 07-11--2016 Declaration of Interest Marie-Claire Pickaert is a full-time
More informationIntellectual Property Management Medicines for Malaria Venture. Life Sciences Symposium WIPO 15 December 2008
Intellectual Property Management Medicines for Malaria Venture Life Sciences Symposium WIPO 15 December 2008 1 Structure of the presentation 1. MMV at a glance - PPP model 2. MMV and Intellectual Property
More informationParenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy)
Parenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy) BACKGROUND (Reason or Purpose) The purpose of this Policy is to provide clear principles and guidance about
More informationThank you for that kind introduction, Billie.
Thank you for that kind introduction, Billie. It is a great honor to be part of this gathering of North Carolina business leaders. Like you, we at GlaxoSmithKline are proud to be a member of the North
More informationPublish your book with CABI KNOWLEDGE FOR LIFE
Publish your book with CABI KNOWLEDGE FOR LIFE CABI: a unique organization that combines research and publishing CABI is an inter-governmental, not-for-profit scientific research and publishing organization
More informationDigital Health Startups A FirstWord ExpertViews Dossier Report
AM PL E PA G ES S A G ES S A FirstWord ExpertViews Dossier Report Published Copyright 2016 Doctor s Guide Publishing Limited All rights reserved. No part of this publication may be reproduced or used in
More informationAnnual Press Conference Financial year 2017
Annual Press Conference 2018 Financial year 2017 Financial year Hubertus von Baumbach Chairman of the Board of Managing Directors 2017 Highly successful financial year 2017 Major success with human pharmaceuticals
More informationRESEARCH PROGRAMME MANAGER for the AntiMicrobial Resistance Benchmark
RESEARCH PROGRAMME MANAGER for the AntiMicrobial Resistance Benchmark The Access to Medicine Foundation is looking for an experienced researcher and manager who will lead the research team in charge of
More informationA COMPREHENSIVE DATABASE OF HIGH-QUALITY RESEARCH. natureindex.com. Track top papers Explore collaborations Compare research performance
Track top papers Explore collaborations Compare research performance A COMPREHENSIVE DATABASE OF HIGH-QUALITY RESEARCH Compare research output across 165 countries Track research from 375,000+ articles
More informationStrategies for Knowledge Translation and Mobilization to Inform Hospital Health Technology Use
Strategies for Knowledge Translation and Mobilization to Inform Hospital Health Technology Use Rosmin Esmail MSc, CHE Director, Knowledge Translation Research, Analytics and Innovation Portfolio Alberta
More informationSynergies and Complementarities with EU Research & Innovation Policy
Synergies and Complementarities with EU Research & Innovation Policy Information Day - EIT 2014 Bernard Mulligan Petra Leroy Cadova Peter Wintlev-Jensen European Commission Budapest, 14 March 2014 Why
More informationAlberta Health Services and Advancing Uptake of HTA & Innovation
Alberta Health Services and Advancing Uptake of HTA & Innovation Don Juzwishin, Candis Bilyk, Rosmin Esmail, Paule Poulin, Dr. Trevor Schuler April 5, 2011 Vancouver, British Columbia Objectives Introduction
More informationPATENT ATTORNEYS TRADE MARK ATTORNEYS
PATENT ATTORNEYS TRADE MARK ATTORNEYS 02 INDEPENDENT THINKING. COLLECTIVE EXCELLENCE. Your intellectual property assets are of great value to you. To help you to secure, protect and exploit them, you need
More informationThe case for quality
The case for quality Around the world, up to two billion people lack access to quality essential medicines. Poor-quality medicines undermine the treatment of some of the world s most pressing diseases,
More informationTECHNOLOGY FOR SCIENTIFICAL ANIMAL HUSBANDRY
TECHNOLOGY FOR SCIENTIFICAL ANIMAL HUSBANDRY 1 2 OUR CUSTOMERS ARE COMMITTED TO WORKING TIRELESSLY IN THE FIGHT AGAINST DISEASES IN HUMANS AND ANIMALS, WHICH EITHER CAN T BE CURED OR FOR WHICH NO REMEDY
More informationStarpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio
More informationThe University of Nairobi is therefore keen to make a follow up on specifics contained in your deliberations.
DVC-RPE Grand Challenges Explorations/BILL & MELINDA GATES Speech The Deputy Vice-Chancellor, Academic Affairs Bill & Melinda Gates Management Team Grand Challenges Explorations Team College Principals
More informationINTRODUCTION OUR VISION: We are driven to be a preeminent college of pharmacy in the world. Our world begins in Iowa. OUR MISSION:
BRAND GUIDE INTRODUCTION TABLE OF CONTENTS BRAND MESSAGING Introduction.... 1 Core Brand Values... 2 BRAND IDENTITY Logo Usage.... 6 Primary Logo Variations.... 7 Department & Division Logos.... 8 What
More informationPolicy for CCG Engagement with the Pharmaceutical Industry
Policy for CCG Engagement with the Pharmaceutical Industry UNIQUE REFERENCE NUMBER: CD/MM/066/V1 DOCUMENT STATUS: DATE ISSUED: October 2014 DATE TO BE REVIEWED: October 2016 Approved by Clinical Development
More informationMCLA Sample eportfolio Submission Instructions Bucket Time
Bucket Time These instructions will help you submit your portfolio pages to our assessment system, also known as our BUCKETS. 1 Contents Log In... 3 Understanding Your eportfolio Homepage... 4 Selecting
More informationResearch and Innovation Strategy and Action Plan UPDATE Advancing knowledge and transforming lives through education and research
Page 1 of 9 Research and Innovation Strategy and Action Plan 2012 2015 UPDATE Advancing knowledge and transforming lives through education and research Executive Summary As the enterprise university, Plymouth
More informationData Sciences for Humanity
washington university school of engineering & applied science strategic plan to achieve leadership though excellence research Data Sciences for Humanity research Data Sciences for Humanity Executive Summary
More informationHorizon Societal Challenge 1: Health, demographic change and wellbeing. Jeremy Bray DG Research & Innovation European Commission
Horizon 2020 Societal Challenge 1: Health, demographic change and wellbeing Jeremy Bray DG Research & Innovation European Commission National NHS day Leeds, UK, 29 January 2014 What is Horizon 2020? The
More informationIntellectual Property Policy. DNDi POLICIES
Intellectual Property Policy DNDi POLICIES DNDi hereby adopts the following intellectual property (IP) policy: I. Preamble The mission of DNDi is to develop safe, effective and affordable new treatments
More informationDOWNLOAD OR READ : RESEARCH FOR MATERIALS DEVELOPMENT IN LANGUAGE LEARNING EVIDENCE FOR BEST PRACTICE PDF EBOOK EPUB MOBI
DOWNLOAD OR READ : RESEARCH FOR MATERIALS DEVELOPMENT IN LANGUAGE LEARNING EVIDENCE FOR BEST PRACTICE PDF EBOOK EPUB MOBI Page 1 Page 2 research for materials development pdf MRS, the Materials Research
More informationCreativity, Collaboration and Identity. Program for an EHRA presidency. Christophe Leclercq
Creativity, Collaboration and Identity Program for an EHRA presidency Christophe Leclercq The mission of the European Heart Rhythm Association is improving the quality of life and reducing sudden cardiac
More informationNIHR ROADSHOW FOR MEDTECH SMES
MARTIN HUNT, DIRECTOR FOR INVENTION FOR INNOVATION (i4i) PROGRAMME, NATIONAL INSTITUTE FOR HEALTH RESEARCH Martin is Programme Director for i4i, a translational funding programme. i4i aims to support and
More informationFREQUENTLY ASKED QUESTIONS
FREQUENTLY ASKED QUESTIONS GSK IP Application Process What is an Industrial Placement at GSK? Our Industrial Placement opportunities at GSK are exclusively for undergraduate university students who are
More informationMaking lives better every day. This is UCB
Making lives better every day. This is UCB Kristof, living with axial spondyloarthritis Remi, UCB Inspired by patients. Driven by science. We have a shared ambition to transform the lives of people living
More informationHealth Informatics Basics
Health Informatics Basics Foundational Curriculum: Cluster 4: Informatics Module 7: The Informatics Process and Principles of Health Informatics Unit 1: Health Informatics Basics 20/60 Curriculum Developers:
More informationBuilding a Personal Portfolio in Blackboard UK SLIS
Building a Personal Portfolio in Blackboard Creating a New Personal Portfolio UK SLIS 1. Enter the Blackboard Course, and select Portfolios Homepage in the Course Menu. 2. In the Portfolios page, you will
More information9 Vaccine SMEs' Needs
9 Vaccine SMEs' Needs As in most innovative sectors, SMEs play a critical role in bridging basic discoveries from academic research to clinical development 36. This could be seen over the last decade with
More informationReview of the University vision, ambition and strategy January 2016 Sir David Bell KCB, Vice-Chancellor
Review of the University vision, ambition and strategy January 2016 Sir David Bell KCB, Vice-Chancellor LIMITLESS POTENTIAL LIMITLESS AMBITION LIMITLESS IMPACT Vision 2026 2 This year we mark our 90th
More informationBioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market
More informationFREQUENTLY ASKED QUESTIONS
FREQUENTLY ASKED QUESTIONS GSK IP Application Process What is an Industrial Placement at GSK? Our Industrial Placement opportunities at GSK are exclusively for undergraduate university students who are
More informationTHE PILLARS THAT SUPPORT US
THE PILLARS THAT SUPPORT US Tradition isn t the enemy, but rather the foundation for audacity. s DR. CHARLES MÉRIEUX THE PILLARS THAT SUPPORT US s OUR COMMITMENT TO PUBLIC HEALTH s OUR SOCIAL COMMITMENT
More informationAstraZeneca 2013 AGM
AstraZeneca 2013 AGM Chief Executive s Remarks 25 April 2013 Introduction Thank you, Leif. Ladies and gentlemen, good afternoon. I would like to add my own welcome to you this afternoon and thank you for
More informationKaro Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business
More informationPATENT ATTORNEYS TRADE MARK ATTORNEYS
PATENT ATTORNEYS TRADE MARK ATTORNEYS INDEPENDENT THINKING. COLLECTIVE EXCELLENCE. Your intellectual property assets are of great value to you. To help you to secure, protect and exploit them, you need
More informationYour Content Your Way
MY VIEW Your Content Your Way My View allows you to view only the topics you want to follow. Choose from a list of available topics, which are individualized for each publications, and design your own
More informationIndiana State University Job Growth Report
State University Job Growth Report STRATEGIC PLAN QUESTION SUBCOMMITTEE REPORT PREPARED BY THOMAS P. MILLER & ASSOCIATES FOR INDIANA STATE UNIVERSITY Executive Summary... 3 Explanation of the data analysis....
More informationTranslational scientist competency profile
C-COMEND Competency profile for Translational Scientists C-COMEND is a two-year European training project supported by the Erasmus plus programme, which started on November 1st 2015. The overall objective
More informationCurrent State of Physician - System - Corporate Joint Ventures
University of Wisconsin-Madison From the SelectedWorks of Vikas Singh May, 2007 Current State of Physician - System - Corporate Joint Ventures Vikas Singh, University of Arkansas for Medical Sciences Available
More informationCOVENANT UNIVERSITY NIGERIA TUTORIAL KIT OMEGA SEMESTER PROGRAMME: MASS COMMUNICATION
COVENANT UNIVERSITY NIGERIA TUTORIAL KIT OMEGA SEMESTER PROGRAMME: MASS COMMUNICATION COURSE: MAC 344 DISCLAIMER The contents of this document are intended for practice and leaning purposes at the undergraduate
More informationResponse to the Western Australian Government Sustainable Health Review
Response to the Western Australian Government Sustainable Health Review On behalf of Australia s digital health community, HISA commends this submission to the Sustainable Health Review Panel, and wish
More informationSUSTAINABLE DEVELOPMENT GOALS CASE STUDY THREE
SUSTAINABLE DEVELOPMENT GOALS CASE STUDY THREE Contributing to the Sustainable Development Goals through science December 2016 DENGUE VACCINE RESEARCH MEXICO Dengue is a tropical disease transmitted by
More informationNHS Next Stage Review: Innovation
NHS Next Stage Review: Innovation January 2008 Introduction 1. The Academy of Medical Sciences welcomes the opportunity to contribute to the NHS Next Stage Review. In this short response we have focused
More informationTRAINING SEMINAR PHARMACEUTICALS AND INTELLECTUAL PROPERTY ACCESS TO MEDICINE: Exploitation of pharmaceutical patents: compulsory licences SESSION 4
TRAINING SEMINAR PHARMACEUTICALS AND INTELLECTUAL PROPERTY 1 12 14 March 2012 Pretoria, South Africa SESSION 4 ACCESS TO MEDICINE: COMMERCIALISATION, DISTRIBUTION, COMPETITION ----------------- Exploitation
More informationCHESS Replacement Project
CHESS Replacement Project Technical Documentation 12 th December 2018 Housekeeping: audio trouble shooting > Check your system requirements > Check that your computer s audio is unmuted > If you are still
More informationCompeting by Saving Lives: How Pharmaceutical and Medical Device Companies Create Shared Value in Global Health
Competing by Saving Lives: How Pharmaceutical and Medical Device Companies Create Shared Value in Global Health March 8, 2012 Boston Geneva Mumbai San Francisco Seattle Washington Contents 1. Plenary Session
More informationRochester, NY October 19, 2013 Page 1 of 5
Rochester, NY October 19, 2013 Page 1 of 5 Speakers: Jane Liesveld, MD Emily Knight, RN, BSN, OCN Emily Knight: I think it would be helpful if we just looked through the Quick Tips part of the binder.
More informationScottish Health and Life Sciences Innovation Workshop. The Industrial Strategy Challenge Fund
Scottish Health and Life Sciences Innovation Workshop The Industrial Strategy Challenge Fund Ian Campbell Innovate UK, Director of Health &Life Sciences Email:Ian.Campbell@innovateuk.gov.uk Twitter: @IanWCampbell
More informationPEAK A MEMBER OF GREAT EAGLE GROUP
PEAK A MEMBER OF GREAT EAGLE GROUP PREFERRED DEVELOPER FOR PREMIUM PROPERTIES. A global brand with international employees, reliable and experienced individuals dedicated to excellence. A trusted partner
More informationEMA Technical Anonymisation Group (TAG)
EMA Technical Anonymisation Group (TAG) Call for applications Presented by Monica Dias, PhD Policy and Crisis Coordinating Officer An agency of the European Union TAG Anonymisation Background The Agency
More informationSchool of Mechanical, Aerospace and Civil Engineering
School of Mechanical, Aerospace and Civil Engineering INDUSTRY INVOLVEMENT Knowledge Transfer Account (KTA) Continuing Professional Development (CPD) Dr Paul Mativenga, Senior Lecturer, Director of External
More informationLocal Production of Pharmaceuticals and Related Technology Transfer UNCTAD/CD-TFT 1. Background
Local Production of Pharmaceuticals and Related Technology Transfer Dr. Padmashree Gehl Sampath Division for Technology and Logistics UNCTAD UNCTAD/CD-TFT 1 1 Background Case studies part of the EU funded
More informationPHARMA S NEW PHASE. Technological integrators play as crucial a role as banks in Big Pharma s latest M&A boom. They re back.
Renew-New PHARMA S NEW PHASE Technological integrators play as crucial a role as banks in Big Pharma s latest M&A boom They re back. Mergers & acquisitions, that is and in a big way. Wall Street and City
More informationAcadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio
More informationTHE BIOMEDICAL ENGINEERING TEACHING & INNOVATION CENTER. at Boston University s College of Engineering
THE BIOMEDICAL ENGINEERING TEACHING & INNOVATION CENTER at Boston University s College of Engineering The vision At Boston University s College of Engineering, we intend to create an exciting new resource
More information